FDA inspection
Bio-Medical Pharmaceutical Manufacturing Corporation: FDA inspection ending Aug 29, 2025
FDA inspection 1279930 · Official Action Indicated (OAI) · Houston, TX
Key facts
| Inspection ID | 1279930 |
|---|---|
| Firm | Bio-Medical Pharmaceutical Manufacturing Corporation |
| FEI number | 1650090 |
| Address | 4311 South Dr |
| City | Houston |
| State | TX |
| ZIP | 77053 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Aug 29, 2025 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 719654 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data